# Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients

> **NCT04880720** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 43 (actual)

## Conditions studied

- SARS-Cov-2 Infection
- Rheumatoid Arthritis

## Interventions

- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT04880720
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-19
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-11-16
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880720, "Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04880720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*